Transverse Thoracic Plane Block, Midpoint Transverse Process Plane to Pleura Block and Erector Spinae Plane Block for Analgesia in Patients Undergoing Thoracoscopic Sympathectomy

Tanta University

Status: Enrolling

Conditions: Erector Spinae Plane Block; Midpoint Transverse Process Plane to Pleura Block; Transverse Thoracic Plane Block; Analgesia; Thoracoscopic Sympathectomy

Treatments: Other: Midpoint transverse process plane to pleura block; Other: Transverse thoracic plane block; Other: Erector spinae plane block

Study type: Interventional

Funder types: Other

Identifiers

NCT06987110

36264PR1182/4/25.

Details and patient eligibility

About

This study compares the transversus thoracic muscle plane block (TTPB), midtransverse to pleura block (MTPB), and erector spinae plane block (ESPB) for postoperative analgesia in patients undergoing thoracoscopic sympathectomy.

Full description

Thoracoscopic sympathectomy is a well-established procedure for the treatment of various hyperhidrosis disorders and certain vascular conditions, involving the division of sympathetic nerve fibers in the thoracic cavity.

The erector spinae plane block (ESPB) is an interfascial regional anesthesia block for thoracic analgesia which can be performed by superficial or deep needle approach.

The mid-transverse to pleura block (MTPB) was first described as a modified paravertebral block.

Transversus thoracic muscle plane block (TTPB) is a newly developed technique in which LA is injected into the fascial plane between the transversus thoracic muscle and the internal intercostal muscles for blocking the anterior cutaneous branches of intercostal nerves from thoracic (Th) 2 to Th 6.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age from 18 to 65 years.
• Both sexes.
• American Society of Anesthesiology (ASA) physical status I-II.
• Scheduled for thoracoscopic sympathectomy

Exclusion criteria

• Coagulopathy.
• History of opiate abuse.
• Pre-existing chronic pain.
• Allergy to local anesthetics or analgesics.
• Infection at the site of injection.
• Mental or neurological disorders.
• Pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

60 participants in 3 patient groups

Transverse thoracic plane block group

Experimental group

Description:

Patients will receive a transverse thoracic plane block.

Treatment:

Other: Transverse thoracic plane block

Midpoint transverse process plane to pleura block group

Experimental group

Description:

Patients will receive a midpoint transverse process plane to pleura block.

Treatment:

Other: Midpoint transverse process plane to pleura block

Erector spinae plane block group

Experimental group

Description:

Patients will receive an erector spinae plane block.

Treatment:

Other: Erector spinae plane block